Search For "morepen laboratories"
Morepen clocks 57 pc growth in Q1 PAT at Rs 30 crore
Updated : 10 months ago IST
New Delhi [India], July 27 (ANI): Morepen Laboratories said on Tuesday it registered a growth of 97 per cent in consolidated profit before tax at Rs 38 crore during the quarter ending June 30.
Read More
India's Morepan Labs manufactures test batch of Russia's Sputnik V vaccine
Updated : 10 months, 3 weeks ago IST
Moscow [Russia], July 6 (ANI): Russian Direct Investment Fund (RDIF) and Indian drug firm Morepen Laboratories on Tuesday announced the production of the test batch of the Russian Sputnik V coronavirus vaccine in an exclusive facility in Himachal Pradesh.
Read More
Morepen approves Rs 433 crore investment from Swiss-based Corinth
Updated : 1 year ago IST
New Delhi [India], May 21 (ANI): Morepen Laboratories said on Friday it has approved an incoming investment of Rs 433 crore to Corinth Investment Holdings AG of Switzerland.
Read More
Morepen seals Rs 750 crore investment from Corinth Group of Switzerland
Updated : 1 year ago IST
New Delhi [India], April 28 (ANI): The board of directors at Morepen Laboratories Ltd on Wednesday approved the investment proposed by Corinth Group, a global private investment firm headquartered in Switzerland, to the extent of 100 million dollars (about Rs 750 crore).
Read More
Morepen labs eyeing multi-billion dollar global market for New API molecul
Updated : 1 year, 3 months ago IST
New Delhi [India], February 12 (ANI/NewsVoir): Morepen Laboratories Ltd. is eyeing an all-new multi-billion dollar global API (Active Pharmaceutical Ingredients) market with the addition of new molecules in its bulk drugs portfolio. The focus areas of these new molecules include chronic and
Read More
Morepen Labs' Performance Catches Pace in Q2'FY2020-21 with a Six-fold Ris
Updated : 1 year, 6 months ago IST
New Delhi [India], November 9 (ANI/NewsVoir): Morepen Laboratories Ltd., a leading API player in regulated markets, has reported a sharp rise of 566 per cent in its Net Profit after Tax (Consolidated) at Rs 27.17 crore in the second Quarter ended September 30th, 2020.
Read More
Morepen Labs' net profit rises by 153 per cent led by strong API business
Updated : 1 year, 8 months ago IST
New Delhi [India], Aug 31 (ANI/NewsVoir): Morepen Laboratories Ltd, a leading API player in regulated markets, has reported a sharp upsurge of 153 per cent in its Net Profit (Consolidated) at Rs 19.37 crore in the first Quarter (Q1) of FY 2020-21 ended June 30th, 2020.
Read More
Morepen Labs clocks Q1 net profit at Rs 19 cr, announces Rs 178 cr expansi
Updated : 1 year, 8 months ago IST
New Delhi [India], Aug 31 (ANI): Morepen Laboratories on Monday reported a sharp upsurge of 153 per cent in its consolidated net profit at Rs 19.37 crore in the quarter ended June as net revenue rose by 27 per cent at Rs 259 crore.
Read More
Morepen Labs clocks double digit growth in its sales and net profit in FY
Updated : 1 year, 11 months ago IST
New Delhi [India], June 22 (ANI/NewsVoir): Morepen Laboratories Ltd has reported a 16.43 per cent rise in its Net Profit (Consolidated) at Rs 33.58 crore.
Read More
Morepen Labs FY20 net profit up 16 pc at Rs 33 crore
Updated : 1 year, 11 months ago IST
New Delhi [India], June 22 (ANI): Morepen Laboratories on Monday reported a 16 per cent rise in its consolidated net profit at Rs 33.6 crore during the financial year ended March while the revenue rose by 11.7 per cent at Rs 862.5 crore.
Read More
Morepen Laboratories gets ISO-13485 certification for its medical devices
Updated : 2 years ago IST
New Delhi [India] April 30 (ANI/NewsVoir): Morepen Laboratories Ltd has received the prestigious ISO-13485 certification from BSI (British Standards Institution, UK) for its state-of-the-art medical devices manufacturing facility at Baddi (Himachal Pradesh).
Read More
Morepen Labs takes up the COVID battle with its infrared thermometers, han
Updated : 2 years, 1 month ago IST
New Delhi [India] April 21 (ANI/NewsVoir): Morepen Laboratories Ltd is all set to be a frontrunner in India's fight against novel coronavirus disease, known as COVID-19.
Read More